Abstract:Objective We previously demonstrated that interleukin‐1 receptor‐mediated immune activation contributes to seizure severity and memory loss in anti‐N‐methyl‐D‐aspartate receptor (NMDAR) encephalitis. In the present study, we assessed the role of the myeloid differentiation primary response gene 88 (MyD88), an adaptor protein in Toll‐like receptor signaling, in the key phenotypic characteristics of anti‐NMDAR encephalitis. Methods Monoclonal anti‐NMDAR antibodies or control antibodies were infused into the lateral ventricle of MyD88 knockout mice (MyD88−/−) and control C56BL/6J mice (wild type [WT]) via osmotic minipumps for 2 weeks. Seizure responses were measured by electroencephalography. Upon completion of the infusion, the motor, anxiety, and memory functions of the mice were assessed. Astrocytic (glial fibrillary acidic protein [GFAP]) and microglial (ionized calcium‐binding adaptor molecule 1 [Iba‐1]) activation and transcriptional activation for the principal inflammatory mediators involved in seizures were determined using immunohistochemistry and quantitative real‐time polymerase chain reaction, respectively. Results As shown before, 80% of WT mice infused with anti‐NMDAR antibodies (n = 10) developed seizures (median = 11, interquartile range [IQR] = 3–25 in 2 weeks). In contrast, only three of 14 MyD88−/− mice (21.4%) had seizures (0, IQR = 0–.25, p = .01). The WT mice treated with antibodies also developed memory loss in the novel object recognition test, whereas such memory deficits were not apparent in MyD88−/− mice treated with anti‐NMDAR antibodies (p = .03) or control antibodies (p = .04). Furthermore, in contrast to the WT mice exposed to anti‐NMDAR antibodies, the MyD88−/− mice had a significantly lower induction of chemokine (C‐C motif) ligand 2 (CCL2) in the hippocampus (p = .0001, Sidak tests). There were no significant changes in the expression of GFAP and Iba‐1 in the MyD88−/− mice treated with anti‐NMDAR or control antibodies. Significance These findings suggest that MyD88‐mediated signaling contributes to the seizure and memory phenotype in anti‐NMDAR encephalitis and that CCL2 activation may participate in the expression of these features. The removal of MyD88 inflammation may be protective and therapeutically relevant.

Dectin-1 limits central nervous system autoimmunity through a non-canonical pathway

Dectin-1 limits CNS autoimmunity through a non-canonical pathway

Dectin-1 signaling in neutrophils up-regulates PD-L1 and triggers ROS-mediated suppression of CD4+ T cells

Cd1-Dependent Regulation of Chronic Central Nervous System Inflammation in Experimental Autoimmune Encephalomyelitis

Inhibition of Dectin-1 Ameliorates Neuroinflammation by Regulating Microglia/Macrophage Phenotype after Intracerebral Hemorrhage in Mice

Analysis of the Cellular Mechanism Underlying Inhibition of EAE after Treatment with Anti-Nkg2a F(ab′)2

Canonical Wnt Signaling in Dendritic Cells Regulates Th1/Th17 Responses and Suppresses Autoimmune Neuroinflammation.

Neuroinflammation triggered by β-glucan/dectin-1 signaling enables CNS axon regeneration

Spatiotemporal Patterns of Dexamethasone-Induced Ras Protein 1 Expression in the Central Nervous System of Rats with Experimental Autoimmune Encephalomyelitis

PGD(2)/DP1 Signaling Deficiency Ameliorates Experimental Autoimmune Encephalitis

Overexpression of the Dominant-Negative Form of Interferon Regulatory Factor 1 in Oligodendrocytes Protects Against Experimental Autoimmune Encephalomyelitis

CSF-1 Maintains Pathogenic but Not Homeostatic Myeloid Cells in the Central Nervous System During Autoimmune Neuroinflammation

The C-type lectin receptor Clec1A plays an important role in the development of experimental autoimmune encephalomyelitis by enhancing antigen presenting ability of dendritic cells and inducing inflammatory cytokine IL-17

Central Nervous System Expression of Interferon Regulatory Factor 1 Regulates Experimental Autoimmune Encephalomyelitis

Prostaglandin D2 signaling in dendritic cells is critical for the development of EAE

Interferon Lambda Signaling Restrains Experimental Autoimmune Encephalomyelitis

MyD88‐mediated signaling is critical for the generation of seizure responses and cognitive impairment in a model of anti‐N‐methyl‐D‐aspartate receptor encephalitis

Notch Ligand Delta-Like 4 Blockade Alleviates Experimental Autoimmune Encephalomyelitis by Promoting Regulatory T Cell Development

Immunoregulation of Experimental Autoimmune Encephalomyelitis by the Selective CB1 Receptor Antagonist.

Daphnetin Alleviates Experimental Autoimmune Encephalomyelitis Via Regulating Dendritic Cell Activity

The role of dectin-1 in health and disease